Kiromic Biopharma Appoints Brian Hungerford As Interim CFO
Portfolio Pulse from Benzinga Newsdesk
Kiromic Biopharma has appointed Brian Hungerford as its Interim CFO, according to an SEC filing. Hungerford brings extensive financial experience to the company.
June 12, 2023 | 8:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Brian Hungerford's appointment as Interim CFO of Kiromic Biopharma may bring stability and financial expertise to the company.
Brian Hungerford's appointment as Interim CFO is directly related to Kiromic Biopharma (KRBP). His extensive financial experience may positively impact the company's financial management and stability in the short term, leading to a potential increase in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100